This
page
is
part
of
the
FHIR
Specification
(v5.0.0:
R5
-
STU
v6.0.0-ballot2:
Release
6
Ballot
(2nd
Draft)
(see
Ballot
Notes
).
This
is
the
The
current
published
version
in
it's
permanent
home
(it
will
always
be
available
at
this
URL).
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R5
R4B
R4
| Clinical Decision Support Work Group | Maturity Level : N/A | Standards Status : Informative | Compartments : No defined compartments |
This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile PlanDefinition .
Generated Narrative: PlanDefinition opioidcds-08
identifier
:
id: urn:oid:2.16.840.1.113883.4.642.11.10,
id: cdc-opioid-guidance (use: OFFICIAL)
Uniform
Resource
Identifier
(URI)
/urn:oid:2.16.840.1.113883.4.642.11.10,
cdc-opioid-guidance (use: official, )
version : 0.1.0
name : Cdcopioid08
title : CDC Opioid Prescribing Guideline Recommendation #8
type
:
ECA
Rule
(
PlanDefinitionType
#eca-rule)
status : draft
date : 2018-03-19
publisher
:
Centers
for
Disease
Control
and
Prevention
(CDC)
HL7
International
/
Clinical
Decision
Support
contact : http://www.hl7.org/Special/committees/dss
description :
Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.
| Code | Value[x] |
|
UsageContextType
focus:
Clinical
Focus
|
Medication
requested
(situation)
|
|
UsageContextType
focus:
Clinical
Focus
|
Chronic
pain
(finding)
|
jurisdiction
:
United
States
of
America
(
ISO
3166-1
Codes
for
the
representation
of
names
of
countries
and
their
subdivisions
—
Part
1:
Country
code
#US)
purpose :
CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.
usage :
Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.
copyright :
© CDC 2016+.
topic
:
Opioid
Prescribing
()
author : Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:
relatedArtifact
type : documentation display : CDC guideline for prescribing opioids for chronic pain document
relatedArtifact
type : documentation display : MME Conversion Tables document
library : http://example.org/fhir/Library/opioidcds-recommendation-08
action
title : Existing patient exhibits risk factors for opioid-related harms.
description :
Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.
Documentations
documentationtype : documentationTypedocumentdocumentation Triggers
Type Name named-event medication-prescribe condition
kind : applicability
Expressions
Description Language Expression Check whether the existing patient exhibits risk factors for opioid-related harms, such as concurrent use with benzodiazepine, a history of substance abuse, and/or an average MME greater than 50 mg/day. text/cql Inclusion Criteria groupingBehavior : visual-group
selectionBehavior : exactly-one
dynamicValue
path : action.description
Expressions
Language Expression text/cql Get Detail dynamicValue
path : action.title
Expressions
Language Expression text/cql Get Summary dynamicValue
path : action.extension
Expressions
Language Expression text/cql Get Indicator Actions
Description Will offer Naloxone instead
Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo
N/A - see comment; snooze 3 mo
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.